PATENT CLAIM ANALYSIS

Application Number: 15900447
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["435", "006000"]

Abstract:
Disclosed herein are prolyl hydroxylase inhibitors that can stabilize hypoxia inducible factor-1 alpha (HIF-1α), as well as hypoxia inducible factor-2 (HIF-2). Also disclosed herein are pharmaceutical compositions comprising one or more of the disclosed compounds. Yet further disclosed are methods for stimulating the cellular immune response in a mammal such as increasing phagocytosis, for example, prolonging the life of phagocytes, inter alia, kerotyiocytes, neutrophils. As such the disclosed compounds provide methods for treating diseases that relate to the body's immune response.

Claim (Index 2):
The compound according to  claim 1 , wherein R 4  is methyl.

Metadata:
- Claim Count in Document: 116.0
- Percentile: 88.0
- Lexical Diversity: 1.52381
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12940891', '12940883', '13768308', '13770135', '14628261']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6910080862153855
- 35 USC 102 Novelty (BERT): 0.6193396315041138
- Combined Prediction Score: 0.6838412407442582
- Mean Citation Score: 548.34156
- Max Citation Score: 556.0568
- Similarity Product: 527.445979469633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test